Silk Road Medical, Inc

NasdaqGS:SILK Rapport sur les actions

Capitalisation boursière : US$1.1b

La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

Silk Road Medical Résultats passés

Passé contrôle des critères 0/6

Silk Road Medical's earnings have been declining at an average annual rate of -3.1%, while the Medical Equipment industry saw earnings growing at 11.2% annually. Revenues have been growing at an average rate of 26.1% per year.

Informations clés

-3.1%

Taux de croissance des bénéfices

23.3%

Taux de croissance du BPA

Medical Equipment Croissance de l'industrie8.9%
Taux de croissance des recettes26.1%
Rendement des fonds propres-36.6%
Marge nette-29.5%
Dernière mise à jour des bénéfices30 Jun 2024

Mises à jour récentes des performances passées

Recent updates

Silk Road Medical, Inc (NASDAQ:SILK) First-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year

May 03
Silk Road Medical, Inc (NASDAQ:SILK) First-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year

Is Silk Road Medical (NASDAQ:SILK) A Risky Investment?

May 02
Is Silk Road Medical (NASDAQ:SILK) A Risky Investment?

Silk Road Medical, Inc's (NASDAQ:SILK) Shares Leap 35% Yet They're Still Not Telling The Full Story

Feb 03
Silk Road Medical, Inc's (NASDAQ:SILK) Shares Leap 35% Yet They're Still Not Telling The Full Story

A Piece Of The Puzzle Missing From Silk Road Medical, Inc's (NASDAQ:SILK) 26% Share Price Climb

Dec 20
A Piece Of The Puzzle Missing From Silk Road Medical, Inc's (NASDAQ:SILK) 26% Share Price Climb

Is Silk Road Medical (NASDAQ:SILK) Weighed On By Its Debt Load?

Nov 03
Is Silk Road Medical (NASDAQ:SILK) Weighed On By Its Debt Load?

Is Silk Road Medical (NASDAQ:SILK) A Risky Investment?

Aug 05
Is Silk Road Medical (NASDAQ:SILK) A Risky Investment?

Shareholders Should Be Pleased With Silk Road Medical, Inc's (NASDAQ:SILK) Price

May 05
Shareholders Should Be Pleased With Silk Road Medical, Inc's (NASDAQ:SILK) Price

Is Silk Road Medical (NASDAQ:SILK) A Risky Investment?

Apr 04
Is Silk Road Medical (NASDAQ:SILK) A Risky Investment?

Silk Road Medical announces $100M common stock offering

Oct 17

Is Silk Road Medical (NASDAQ:SILK) Using Too Much Debt?

Sep 24
Is Silk Road Medical (NASDAQ:SILK) Using Too Much Debt?

Silk Road Medical GAAP EPS of -$0.44 beats by $0.02, revenue of $33.17M beats by $2.14M

Jul 26

Silk Road Medical: Divergence From Alternative Risk Premia Means Lack Of Upside Capture

Jul 19

Silk Road Medical falls after Citigroup downgrades to Sell from Neutral

Jul 11

Is Silk Road Medical (NASDAQ:SILK) Using Too Much Debt?

Jun 09
Is Silk Road Medical (NASDAQ:SILK) Using Too Much Debt?

Silk Road Medical - What A Road It Has Been

Apr 08

Ventilation des recettes et des dépenses

Comment Silk Road Medical gagne et dépense de l'argent. Sur la base des derniers bénéfices déclarés, sur une base LTM.


Historique des gains et des recettes

NasdaqGS:SILK Recettes, dépenses et bénéfices (USD Millions )
DateRecettesLes revenusDépenses G+ADépenses de R&D
30 Jun 24191-5716043
31 Mar 24185-5315242
31 Dec 23177-5614541
30 Sep 23170-5513840
30 Jun 23163-5313139
31 Mar 23151-5512339
31 Dec 22139-5511636
30 Sep 22127-5711135
30 Jun 22114-6110833
31 Mar 22107-5610230
31 Dec 21101-509627
30 Sep 2194-529030
30 Jun 2190-488427
31 Mar 2178-487724
31 Dec 2075-477621
30 Sep 2073-397314
30 Jun 2070-377113
31 Mar 2070-386913
31 Dec 1963-526312
30 Sep 1956-605712
30 Jun 1949-614912
31 Mar 1942-564211
31 Dec 1835-383510
31 Dec 1714-19207

Des revenus de qualité: SILK is currently unprofitable.

Augmentation de la marge bénéficiaire: SILK is currently unprofitable.


Analyse des flux de trésorerie disponibles par rapport aux bénéfices


Analyse de la croissance passée des bénéfices

Tendance des revenus: SILK is unprofitable, and losses have increased over the past 5 years at a rate of 3.1% per year.

Accélération de la croissance: Unable to compare SILK's earnings growth over the past year to its 5-year average as it is currently unprofitable

Bénéfices par rapport au secteur d'activité: SILK is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (5.5%).


Rendement des fonds propres

ROE élevé: SILK has a negative Return on Equity (-36.55%), as it is currently unprofitable.


Rendement des actifs


Rendement des capitaux employés


Découvrir des entreprises performantes dans le passé